ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,151,000 | +37.2% | 12,498 | 0.0% | 0.10% | +23.1% |
| Q2 2021 | $1,568,000 | -7.5% | 12,498 | 0.0% | 0.08% | 0.0% |
| Q1 2021 | $1,695,000 | +6.0% | 12,498 | 0.0% | 0.08% | +9.9% |
| Q4 2020 | $1,599,000 | +13.7% | 12,498 | 0.0% | 0.07% | -12.3% |
| Q3 2020 | $1,406,000 | +18.1% | 12,498 | 0.0% | 0.08% | -1.2% |
| Q2 2020 | $1,191,000 | +6.1% | 12,498 | 0.0% | 0.08% | -7.9% |
| Q1 2020 | $1,123,000 | +69.4% | 12,498 | 0.0% | 0.09% | +102.3% |
| Q4 2019 | $663,000 | +34.2% | 12,498 | 0.0% | 0.04% | +69.2% |
| Q3 2019 | $494,000 | -3.7% | 12,498 | 0.0% | 0.03% | +23.8% |
| Q2 2019 | $513,000 | -11.9% | 12,498 | 0.0% | 0.02% | -16.0% |
| Q1 2019 | $582,000 | +7.0% | 12,498 | 0.0% | 0.02% | -24.2% |
| Q4 2018 | $544,000 | -23.9% | 12,498 | 0.0% | 0.03% | -15.4% |
| Q3 2018 | $715,000 | +18.0% | 12,498 | 0.0% | 0.04% | -18.8% |
| Q2 2018 | $606,000 | +23.9% | 12,498 | 0.0% | 0.05% | +65.5% |
| Q1 2018 | $489,000 | -7.7% | 12,498 | 0.0% | 0.03% | -17.1% |
| Q4 2017 | $530,000 | +13.7% | 12,498 | 0.0% | 0.04% | +52.2% |
| Q3 2017 | $466,000 | +22.6% | 12,498 | 0.0% | 0.02% | +15.0% |
| Q2 2017 | $380,000 | +14.8% | 12,498 | 0.0% | 0.02% | -13.0% |
| Q1 2017 | $331,000 | -79.1% | 12,498 | -79.9% | 0.02% | -79.1% |
| Q4 2016 | $1,585,000 | – | 62,105 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 1,400,000 | $133,378,000 | 3.73% |
| Foresite Capital Management III, LLC | 42,030 | $4,004,000 | 3.56% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 257,249 | $24,508,000 | 2.23% |
| Cormorant Asset Management, LP | 600,000 | $57,162,000 | 2.18% |
| Avoro Capital Advisors LLC | 1,040,000 | $99,081,000 | 1.96% |
| QVT Financial LP | 101,396 | $9,660,000 | 1.64% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,100,000 | $200,067,000 | 1.60% |
| Rhenman & Partners Asset Management AB | 155,000 | $14,767,000 | 1.60% |
| Parkman Healthcare Partners LLC | 57,500 | $5,478,000 | 1.54% |
| Ikarian Capital, LLC | 187,700 | $17,882,000 | 1.42% |